Objective: The purpose of this study was to determine the role of surgical treatment and to identify factors affecting the survival of patients undergoing pulmonary resection for tumors metastatic from head and neck carcinomas. Methods: Thirty-three patients who had undergone resection of pulmonary tumors metastatic from head and neck carcinomas, other than thyroid cancers and sarcomas of the head and neck, were reviewed. Results: The operative morbidity rate was only 6%, no patients died within 30 days after resection and complete resection was achieved in 94% of patients. The overall 1-and 3-year survival rates were 76% and 43%, respectively, and the median survival time was 21 months. The factors found on univariate analysis to significantly affect survival were a diseasefree interval of 2 years, tongue carcinoma and squamous cell carcinoma. The factor found, on multivariate analysis, to most strongly affect survival was tongue carcinoma. The most frequent pattern of initial recurrence after pulmonary resection was distant metastasis (64%). Conclusions: The safety and effectiveness of surgical treatment for pulmonary tumors metastatic from head and neck carcinomas in adaptive criteria for resection are well demonstrated. The poor survival after surgical resection of pulmonary tumors metastatic from cancers of the tongue should be noted.
INTRODUCTION
Local and regional control of head and neck cancers has improved through the use of multimodal treatment combining surgical resection, radiation and chemotherapy. However, no effective or beneficial systemic treatment has been established for head and neck cancers that have metastasized to distant sites. The anticipated incidence of clinically detected distant metastases from head and neck cancers ranges from 5.5% to 40% (1 -7) . The most common site of metastasis is the lung (8 -10) . Nevertheless, surgical resection has become the standard treatment for selected pulmonary tumors metastatic from a variety of malignancies, including sarcomas, germ cell tumors, renal cell cancers and colorectal cancers. However, for patients with head and neck cancers, few studies have examined the role of pulmonary resection, and the clinical factors that best predict outcome remain unclear. The purpose of this study was to present our experiences with pulmonary resection of epithelial head and neck cancers and to clarify factors affecting survival according to the primary site of head and neck carcinomas.
PATIENTS AND METHODS

PATIENT POPULATION
From October 1992 through November 2006, 41 patients with pulmonary metastatic tumors who had been treated for head and neck malignant tumors underwent surgical resection at the National Cancer Center Hospital East. All patients who underwent pulmonary resection for metastatic tumors met the following criteria: (i) head and neck primary cancer controlled or imminently controllable; (ii) metastatic disease limited to the lung; (iii) pre-operative assessment of complete respectability of all pulmonary lesions; and (iv) ability to tolerate the planned pulmonary resection. Excluded from the study were five patients with thyroid cancers, one patient with chondrosarcoma and two patients with incomplete clinical information. Therefore, 33 patients with complete clinical and pathological data were retrospectively analyzed.
Pre-operative clinical staging for primary carcinomas of the head and neck was based on the 1997 International Union Against Cancer TNM classification. All pathological specimens were examined by pathologists with specific experience with tumors of the head and neck and of the lung. Pulmonary lesions were diagnosed as metastatic tumors when they showed histological similarity to the primary tumor of the head and neck and when possibility of a second primary lung malignancy had been excluded. Lesions that had originated within the bronchus were diagnosed as second primary lung tumors.
SURGERY
The aim of surgery for lung tumors was complete resection. The most common procedure was wedge resection, which was performed for 17 of the 33 patients. Lobectomy was performed for 12 patients, and segment resection was performed for 4 patients ( Table 2) . Systemic lymph node dissection was not performed.
FOLLOW-UP
After discharge, all 33 patients were regularly followed up with routine physical and laboratory examinations at our hospital. Chest radiography, external ultrasonography of the neck and computed tomography of the neck and the chest were performed annually to detect possible recurrent disease. The median follow-up period was 21 months (range, 4 -128 months).
STATISTICAL ANALYSIS
The disease-free interval was calculated from the date of the start of definitive treatment of the head and neck cancer to the date of the diagnosis of the pulmonary metastasis with radiological examinations. Survival time was defined as the interval from the date of initial resection of lung tumors to the date of last follow-up or death. Length of survival was determined with the Kaplan -Meier method, and the log-rank test was used for comparison. Multivariate analysis was performed with the Cox proportional hazard model. A P value of ,0.05 was considered to indicate significance. All analyses were performed with the SPSS statistical software package (version 11.0; SPSS, Inc., Chicago, IL, USA).
RESULTS
CLINICAL CHARACTERISTICS FOR HEAD AND NECK CARCINOMAS
The characteristics of the primary head and neck carcinomas are shown in Table 1 . Twenty-five patients were men and eight were women. The median patient age was 59 years, and the age range was 22 -83 years. The primary sites of the head and neck carcinomas were as follows: hypopharynx in eight cases, the larynx in six cases, the oropharynx in three 
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The role of pulmonary resection from HN carcinomas cases, the tongue in seven cases, the nasopharynx in four cases and major or minor salivary glands in five cases. Most patients presented with T3 or T4 and Stage IV disease. Three patients with M1 disease had a synchronous pulmonary metastasis. The initial treatment for the primary tumors was surgical resection for 26 patients and radiation or chemoradiation for seven patients. The histological type of the primary tumor was squamous cell carcinoma (SCC) in 27 patients and other in 6 patients. The other histological types were as follows: adenocarcinoma in two patients, adenoid cystic carcinoma in two patients, undifferentiated carcinoma in one patient and salivary gland carcinoma in one patient.
PULMONARY CLINICAL FEATURES AND RESECTION
Clinical features of lung tumor and results of pulmonary resection are shown in Table 2 . Three of the 33 patients with synchronous pulmonary tumors underwent resection after surgical resection of the primary tumor. Thirty-one (94%) patients had a solitary lung tumor, but two patients had two lung tumors. One of these two patients underwent bilateral thoracotomy at the same time, and the other patient twice underwent wedge resection by unilateral thoracotomy. All lung tumors in the 33 patients were pathologically diagnosed and confirmed to be metastases from head and neck carcinomas. Complete resection of metastatic tumors in the lung was achieved in 94% of the patients. The overall rate of postoperative complications was 6%; two patients had pneumonia but did not require mechanical ventilation. No patients died in the 30 days after surgery.
PATTERNS OF FIRST FAILURE
Disease recurred after pulmonary resection in 21 patients (64%). Distant metastasis, especially to the lung, was the most common pattern of recurrence after resection (Table 3) .
SURVIVAL AND FACTORS AFFECTING SURVIVAL IN UNIVARIATE AND MULTIVARIATE ANALYSES
The overall 1-and 3-year survival rates of the 33 patients were 76% and 43%, respectively, and the median survival time was 21 months. The overall survival curves according to the sites of primary head and neck tumors are shown in Fig. 1 . The overall 1-and 3-year survival rates of patients with salivary gland tumors were each 80%. The overall 1-and 3-year survival rates of patients with nasopharynx and oropharynx were each 86%. The overall 1-and 3-year survival rates of patients with tumors of the larynx and hypopharynx were 79% and 25%, respectively. In patients with tumors of the tongue, the overall 1-year survival rate after resection was 57% and the median survival time was 13 months; no patient survived for .2 years. Significant prognostic factors identified with univariate analysis were a disease-free interval of 2 years, a primary tumor of the Figure 1 . Overall survival curves according to location of primary tumors. tongue and SCC ( Fig. 2 and Table 4 ). The most significant prognostic factor identified with multivariate analysis was carcinoma of the tongue (Table 5 ).
DISCUSSION
The most common site of distant metastasis in patients with head and neck carcinomas is the lung (8 -10). Furthermore, patients with head and neck cancers are at high risk for metachronous primary lung cancers (11, 12) . The relative risk of a lung carcinoma developing in patients who have been treated for an SCC of the head and neck is three to six times higher than in a healthy population (13, 14) . Therefore, pulmonary malignances are a major problem after definitive treatment of head and neck malignancies. Distinguishing a pulmonary metastasis from a primary lung cancer in patients with head and neck SCC has been difficult because of the similarities in histopathological and radiographic appearance. However, the molecular genetic approach has helped clarify the fundamental distinction between pulmonary metastases and primary lung cancers (15, 16) . By comparing loss of loci on chromosome arms 3p and 9p between paired SCCs of the head and neck and of the lung, Leong et al. (16) have found that the pulmonary SCCs were metastases rather than independent lung carcinomas in 12 (75%) of 16 patients. Geurts et al. (15) have reported that loss of heterozygosity analysis suggested that tumors of the lung diagnosed as metastatic SCCs in 19 (50%) of 38 patients were in fact second primary lung carcinomas. Treatment strategies for primary lung cancers differ from those for metastases to the lung from head and neck carcinomas. For resectable second primary lung cancers, surgical intervention with curative intent should be considered (17) , but for lung metastases, systemic therapy or limited surgical resection should be considered. The survival benefit from surgical resection after the treatment of SCCs of the head and neck might be expected to be greater for patients with primary lung cancers than for patients with metastasis to the lung. However, no significant difference in survival has been found between these groups of patients (14) . Distant metastasis is considered to be a systemic disease and is generally treated with chemotherapy. However, the results of chemotherapy for pulmonary metastases have been 
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The role of pulmonary resection from HN carcinomas extremely poor, with few complete responses and short survival (7) . In contrast, surgical resection has become the standard therapy for selected cases of a variety of malignancies metastatic to the lung, including sarcomas, germ cell tumors, renal cell cancers and colorectal cancers. However, there have been few reports of surgical resection of pulmonary metastases from head and neck carcinomas. Although previous reports have demonstrated the safety of surgical resection and its effect on survival, independent prognostic factors remain unclear. Therefore, the aim of the present study was to confirm the role of surgical resection for pulmonary metastases from such tumors and to identify factors affecting survival according to the site of the primary tumor of the head and neck. The safety and curativity of resection for malignant tumors of the lung are well established (7, 18, 19) ; in the present study, no patients died within 30 days after resection, and complete resection was achieved in 94% of the patients. In addition, the 5-year survival rates of previous reports have been excellent, ranging from 29% to 59% (6, 7, 19, 20) . The overall 3-year survival rate in our series (43%) was similar to rates in previous studies. Surgical treatment for pulmonary metastases from head and neck carcinomas in selected patient is a safe and therapeutically beneficial procedure. There is little doubt that such favorable outcomes depend on good locoregional control of primary tumors and careful selection of candidates. Several factors affecting survival have been reported. Factors reported to be associated with poor survival include the histological diagnosis of SCC, site of oral cavity, disease-free interval of 2 years, incomplete resection, older patients, male sex, mediastinal lymph node involvement and multiple metastases (6,7,18 -22) . In our study, the significant factors affecting survival identified with univariate analysis were a disease-free interval of 2 years, tongue carcinoma and SCC. On multivariate analysis, tongue carcinoma was the most significant factor affecting survival. In general, the disease-free interval and the histological diagnosis of SCC are considered the most reliable prognostic factors. In our study and that of Liu et al. (18) , a disease-free interval of 2 years was associated with a poor prognosis, and Finley et al. (7), Chen et al. (21), Nibu et al. (22) and Wedman et al. (6) have found that a disease-free interval of 1 year is a poor prognostic factor. After all, a short diseasefree interval is predictive of a negative outcome. There is little doubt that SCC is associated with poor survival (6, 18, 21, 22) . However, few studies have examined prognostic factors according to the site of head and neck primary tumors. Mazer et al. (19) and Nibu et al. (22) have found that a primary tumor of the oral cavity has a significantly poorer than do tumors of other sites. Although the oral cavity includes numerous subsites, such as the buccal mucosa, upper gums, lower gums, hard palate, floor of the mouth and tongue, these studies did not describe these subsites in detail. Our present study found that primary tumors of the tongue had a significantly poorer prognosis than did tumors of other sites. However, we could not elucidate causal relationship between primary tumors of the tongue and poor prognosis. To our knowledge, our study is the first to report factors significantly associated with a poor prognosis according to subsites of the primary tumor. The notion that multiple metastases and mediastinal lymph node involvement affect survival is controversial because contradictory results have been obtained from studies with small numbers of patients (7, 19, 20, 22, 23) . At our institution, systemic mediastinal and hilar lymph node dissection is performed only when enlarged lymph nodes are observed on radiological examination. There was no statistically significant difference in survival between the number of metastases (P ¼ 0.54). We would consider performing resection of bilateral pulmonary lesions, multiple tumors or both if the patients met the criteria for pulmonary resection for metastatic tumors. We could not detect a statistically significant difference in survival between patients with different T factors, N factors or stage of the primary tumor. Nibu et al. (22) and Wedman et al. (6) have also found that the TNM stage of the primary tumor was not correlated with survival after pulmonary resection for metastatic tumors. In the present study, disease recurred after pulmonary resection in 64% of the patients (21 of 33 patients). Distant metastasis, especially to the lung, was the most frequent pattern of recurrence after pulmonary resection.
CONCLUSIONS
We believe that pulmonary resection should be attempted in patients with pulmonary tumors, regardless of whether the tumors are single or multiple, if the patients meet the criteria for pulmonary resection of metastatic tumors. We have confirmed that pulmonary resection after the treatment of head and neck carcinomas is safe and increases the likelihood of long-term survival. We found that the factors of a diseasefree interval ,2 years, a histological diagnosis of SCC and a primary site of the tongue are negatively correlated with survival. However, the lack of long-surviving patients who have undergone surgical resection for pulmonary tumors metastatic from primary tumors of the tongue should be taken into account. The pattern of initial recurrence after pulmonary resection was most often distant metastasis (64%). Therefore, adjuvant systemic chemotherapy after pulmonary resection might help prolong survival.
